Intervenční a akutní kardiologie,
Journal Year:
2024,
Volume and Issue:
23(2-3), P. 103 - 107
Published: Dec. 12, 2024
Prezentujeme
málo
častou
možnost
využití
mechanické
srdeční
podpory
Impella
CP
Smart
Assist
(Abiomed)
zavedené
přes
biologickou
aortální
náhradu
Evolut
(Medtronic).
Mezi
absolutní
kontraindikace
zavedení
Impelly
se
řadí
mj.
i
přítomnost
protézy
chlopně,
ne
však
bioprotéza
v
pozici.
Před
zaváděním
bioprotézu
varuje
americká
FDA
z
důvodu
rizika
interakcí
mezi
in-flow
a
out-flow
okrajem
stentu
s
možností
poškození
funkce
pumpy.
Přesto
může
být
této
u
pacientů
implantovanou
stentovanou
chlopní
někdy
nezbytné,
především
při
vysoce
rizikové
PCI
nebo
případě
kardiogenního
šoku,
kdy
není
vhodné
možné
použít
jinou
oběhovou
levokomorovou
podporu.
V
článku
jsou
popsány
některé
praktické
tipy,
jak
lze
postupovat
případě,
že
je
nutno
Impellu
do
těchto
stentovaných
chlopní,
zavést
prezentujeme
naši
zkušenost
na
konkrétním
případu.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(2), P. 341 - 341
Published: Jan. 7, 2024
Over
the
last
decades,
bioprosthetic
heart
valves
(BHV)
have
been
increasingly
implanted
instead
of
mechanical
in
patients
undergoing
surgical
aortic
valve
replacement
(SAVR).
Structural
deterioration
(SVD)
is
a
common
issue
at
follow-up
and
can
justify
need
for
reintervention.
In
evolving
landscape
interventional
cardiology,
valve-in-valve
transcatheter
(ViV
TAVR)
has
emerged
as
remarkable
innovation
to
address
complex
challenges
previously
treated
with
SAVR
rapidly
gained
prominence
feasible
technique
especially
high
risk.
On
other
hand,
expanding
indications
TAVR
progressively
younger
severe
stenosis
pose
crucial
question
on
long-term
durability
(THVs),
might
outlive
valve.
this
review,
we
provide
an
overview
role
ViV
failed
BHVs,
specific
focus
current
clinical
evidence,
pre-procedural
planning,
procedural
techniques,
possible
complications.
The
combination
integrated
Heart
Team
discussion
growth
curve
makes
it
achieve
best
results
avoid
complications
or
put
oneself
ahead
time
from
them.
Journal of Endovascular Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 1, 2024
Purpose:
To
assess
the
feasibility
and
safety
of
intravascular
lithotripsy
(IVL)
for
enabling
transfemoral
abdominal
(EVAR),
thoracic
(TEVAR),
thoracoabdominal
(BEVAR)
endovascular
aneurysm
repair
in
patients
with
narrow
calcified
iliac
arteries.
Materials
methods:
Consecutive
treated
IVL
severe
narrowed
access
before
EVAR,
TEVAR,
or
BEVAR
between
November
2020
June
2022
were
retrospectively
evaluated.
All
anatomical
characteristics
acquired
by
multi-planar
reconstruction
preoperative
computed
tomography
angiography
(CTA).
The
hostility
vascular
accesses
was
classified
based
on
Peripheral
Arterial
Calcium
Scoring
System
(PACSS)
severity
score
(CASS),
a
new
considering
both
(calcium
grade
length,
minimum
lumen
diameter
[MLD],
tortuosity
index)
aortic
stent-graft
(SG/MLD
parameters.
Primary
endpoint
technical
success
defined
as
successful
endograft
delivery
deployment
without
rupture.
Freedom
from
complications
primary
patency
additionally
analyzed.
Results:
Twenty-eight
axes
(8
bilateral)
20
(mean
age
74.5±6.7
years)
mean
follow-up
26.5±6.2
(range
17–36)
months.
Ten
underwent
EVAR:
3
7
procedures.
In
14
(70%),
disease
associated
symptomatic
aorto-iliac
occlusive
(AIOD),
Rutherford
class
III
to
IV.
PACSS
IV
89%
cases
CASS
14±2)
all
cases.
(SG)
outer
(5.60±1.65
mm)
significantly
larger
50%
than
MLD
(3.96±1.20
mm),
an
SG/MLD
index
1.50±0.51
(p<0.001).
Technical
100%.
No
dissection,
rupture,
distal
embolization
occurred.
One
(3.4%)
bail-out
stenting
necessary
endoconduit
after
treatment.
month
CTA
showed
that
postoperative
luminal
gain
increased
93%
An
improvement
2
classes
occurred
AIOD
100%
at
last
follow-up.
Conclusions:
This
study
shows
valuable
option
treat
arteries
facilitate
delivery.
Further
studies
will
be
useful
confirm
these
results.
Clinical
Impact
this
article,
use
artery
is
explored.
presence
calcifications
still
represents
contraindication
repair.
Intravascular
increases
procedures,
facilitating
reducing
risk
rupture
and/or
dissections
improving
vessel
compliance
gain.
novel
preparation
could
alternative
“paving
cracking”
conduits.
describes
classify
calcifications,
parameters
profile
endografts
system.
Expert Review of Medical Devices,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 10
Published: Feb. 25, 2025
Peripheral
arterial
disease
(PAD)
complicates
endovascular
interventions
due
to
vascular
calcifications,
which
compromise
procedural
success
and
long-term
outcomes.
Intravascular
lithotripsy
(IVL)
represents
a
promising
innovation
modify
calcified
lesions
with
shockwaves,
addressing
unmet
clinical
needs.
This
review
explores
the
mechanisms,
devices,
applications
of
IVL
in
PAD
treatment.
It
highlights
limitations
conventional
approaches
(high-pressure
balloons,
specialty
atherectomy),
often
result
suboptimal
lesion
preparation
complications.
Particular
emphasis
is
placed
on
combination
atherectomy
IVL,
as
well
various
devices
available
development,
beyond
those
from
Shockwave
Medical.
Additionally,
we
discuss
future
perspectives,
including
drug
penetration
enhancement
issue
post-IVL
recoil.
literature
methodology,
encompassing
searches
PubMed
Embase,
January
2008
December
2023,
briefly
outlined.
offers
safe,
effective,
innovative
approach
treating
while
preserving
surrounding
tissues.
However,
current
evidence,
mainly
derived
industry-funded
studies,
limited
by
heterogeneous
calcification
classifications
lack
outcome
data.
Independent
research
essential
define
IVL's
role
treatment
algorithms,
especially
regarding
its
cost-effectiveness
primary
patency
Journal of Clinical Medicine,
Journal Year:
2025,
Volume and Issue:
14(5), P. 1651 - 1651
Published: Feb. 28, 2025
Transcatheter
aortic
valve
replacement
(TAVR)
was
introduced
in
2002
and
has
become
integral
the
management
of
stenosis.
As
an
alternative
to
surgical
replacement,
it
relies
heavily
on
safe
access
annulus
for
implantation
a
prosthesis.
Throughout
its
development
current
practice,
transfemoral
(TF)
arterial
route
retrograde
delivery
been
primary
approach.
However,
this
is
not
appropriate
all
patients,
which
led
multiple
alternate
options.
This
review
discusses
TAVR,
followed
by
thorough
discussion
TF
access.
The
commercially
available
products,
preprocedural
planning,
closure
techniques,
procedural
complications
are
discussed.
We
also
describe
various
routes
with
particular
emphasis
most
recently
developed
route,
transcaval
(TCv),
focus
indications,
technical
considerations,
comparative
outcomes.
TAVR
technology,
availability
expand,
knowledge
implementation
utmost
importance.
Journal of Clinical Medicine,
Journal Year:
2023,
Volume and Issue:
12(4), P. 1342 - 1342
Published: Feb. 8, 2023
Transcatheter
aortic
valve
implantation
(TAVI)
went
through
a
huge
evolution
in
the
last
decades.
Previously
performed
under
general
anesthesia,
with
transoperative
transesophageal
echocardiography
guidance
and
using
cutdown
femoral
artery
access,
procedure
has
now
evolved
into
minimalist
approach,
local
conscious
sedation,
avoidance
of
invasive
lines
becoming
new
standards.
Here,
we
discuss
TAVI
approach
how
incorporate
it
our
current
clinical
practice.
VASA,
Journal Year:
2024,
Volume and Issue:
53(4), P. 263 - 274
Published: June 27, 2024
Heavily
calcified
peripheral
artery
lesions
increase
the
risk
of
vascular
complications,
constituting
a
severe
challenge
for
operator
during
catheter-based
cardiovascular
interventions.
Intravascular
Lithotripsy
(IVL)
technology
disrupts
subendothelial
calcification
by
using
localized
pulsative
sonic
pressure
waves
and
represents
promising
technique
plaque
modification
in
patients
with
arteries.
Journal of Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
13(12), P. 3386 - 3386
Published: June 9, 2024
Transcatheter
aortic
valve
replacement
(TAVR)
has
emerged
as
an
alternative
treatment
option
for
patients
with
severe
stenosis
regardless
of
surgical
risk,
particularly
in
those
a
high
and
prohibitive
risk.
Since
the
advent
TAVR,
transfemoral
access
been
standard
care.
However,
given
comorbidities
anatomical
limitations,
proportion
are
not
good
candidates
approach.
Alternative
access,
including
transapical,
transaortic,
transaxillary,
transsubclavian,
transcarotid,
transcaval,
can
be
considered.
Each
advantages
disadvantages,
so
vascular
route
should
tailored
to
patient’s
characteristics.
there
is
no
standardized
algorithm
when
choosing
optimal
access.
In
this
review,
we
analyzed
evolution
current
evidence
most
common
TAVR
proposed
patient
population.
Vascular,
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 28, 2024
Background
Intravascular
lithotripsy
has
proven
to
be
safe,
less
invasive,
and
effective
for
coronary
peripheral
arteries,
the
indication
been
extended
aortic
district
but
there
is
still
little
evidence
in
literature
as
only
a
few
cases
have
described
so
far.
Method
We
report
case
of
intravascular
infrarenal
aorta
due
coral
reef,
chronic
occlusion
using
single
Shockwave
M5
+
balloon,
followed
by
covered
stent
deployment.
The
bifurcation
common
iliac
arteries
presented
hemodynamic
calcific
lesions,
which
were
prepared
singularly
with
before
aorto-iliac
stenting
kissing
configuration.
length
from
arises
inferior
mesenteric
lumbar
was
left
uncovered
preserving
their
patency.
Result
In
this
case,
shockwave
balloon
sufficient
treat
successfully
safely
heavy
lesions.
At
1
6
months
follow-up,
patient
had
no
clinical
symptoms,
ultrasound
assessment
showed
triphasic
waveform
at
femoral
bilaterally
confirmed
patency
grafts.
Conclusion
Selective
assisted
vessels
possible,
definitive
outcomes
yet
supported
literature.